Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 9, 2022
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
[ Fri, Sep 09th 2022
] - WOPRAI
Thu, September 8, 2022
[ Thu, Sep 08th 2022
] - WOPRAI
Kristen Kluska Initiated (ATNM) at Buy and Held Target at $20 on, Sep 8th, 2022
Kristen Kluska of Cantor Fitzgerald, Initiated "Actinium Pharmaceuticals, Inc." (ATNM) at Buy and Held Target at $20 on, Sep 8th, 2022.
Kristen has made no other calls on ATNM in the last 4 months.
There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Kristen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kristen
- Yuan Zhi of "B. Riley Securities" Initiated at Strong Buy and Held Target at $16 on, Thursday, August 25th, 2022
